Sequana Medical NV develops and commercializes treatments for patients with diuretic-resistant fluid overload in liver disease, cancer, and heart failure in Belgium, Germany, France, and internationally. The company offers alfapump system, an implantable pump system for the treatment of refractory liver ascites and malignant ascites; and Direct Sodium Removal (DSR) for the treatment of fluid overload spread across the body. Sequana Medical NV was founded in 2006 and is headquartered in Gent, Belgium.
Show more...
FAQ
Sequana medical NV 今天的股價是多少?▼
2SE.F 目前價格為 €0.44 EUR,過去 24 小時上漲了 +12.9%。在圖表上更密切關注 Sequana medical NV 股價表現。
Sequana medical NV 的股票代號是什麼?▼
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,Sequana medical NV 的股票以代號 2SE.F 進行交易。
Sequana medical NV 的股價在上漲嗎?▼
2SE.F 股票較上週上漲 +9.54%,本月下跌 -25.08%,過去一年 Sequana medical NV 下跌 -51.11%。
Sequana medical NV 的市值是多少?▼
今天 Sequana medical NV 的市值為 25.29M
Sequana medical NV 下一次財報日期是什麼時候?▼
Sequana medical NV 將於 September 03, 2026 公布下一次財報。
Sequana medical NV 去年的營收是多少?▼
Sequana medical NV 去年的營收為 210,000EUR。
Sequana medical NV 去年的淨利是多少?▼
2SE.F 去年的淨收益為 -89.31MEUR。
Sequana medical NV 有多少名員工?▼
截至 April 05, 2026,公司共有 48 名員工。
Sequana medical NV 位於哪個產業?▼
Sequana medical NV從事於Health Care產業。
Sequana medical NV 何時完成拆股?▼
Sequana medical NV 最近沒有進行任何拆股。
Sequana medical NV 的總部在哪裡?▼
Sequana medical NV 的總部位於 BE 的 Gent。